Divergence raises funds for nematode control
The US biotechnology company, Divergence (St Louis, Missouri), has raised $11.8 million from institutional investors. The proceeds will be used to support the development of nematicides and nematode-resistant crops. Divergence claims to have discovered the first new mode of action in nematicides for 20 years. Its compounds have health and environmental profiles “vastly superior to traditional nematicides”, the company says. Divergence is collaborating with Monsanto on the development of nematode-resistant soybeans ( Agrow No 512, p 3).